Chicago —(ENEWSPF)—July 23, 2018 By: Rosemary Piser Attorney General Lisa Madigan joined eight other Attorneys General filing comments urging the Food and Drug Administration’s (FDA) to ban flavored tobacco products in e-cigarettes, little cigars and other non-combustible products. The Attorneys General point out that research shows flavored tobacco products are appealing[Read More…]
Science
Study: Medical Cannabis Access Associated With Significant Reduction In Prescription Opioid Use
San Diego, CA—(ENEWSPF)—July 19, 2018 By: Paul Armentano The enactment of medical cannabis access laws is associated with significant reductions in prescription opioid use among Medicaid enrollees, according to data published online ahead of print in the journal Addiction. Investigators with the University of California at San Diego assessed the[Read More…]
Hy-Vee Voluntarily Recalls Spring Pasta Salad Due to Reported Illnesses
Silver Spring, Maryland—(ENEWSPF)—July 19, 2018 Contact: Tina Potthoff Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling its Hy-Vee Spring Pasta Salad due to the potential that it may be contaminated with Salmonella. The potential for contamination was brought to Hy-Vee’s attention last night when approximately 20 illnesses[Read More…]
From Crib To Court: Trump Administration Summons Immigrant Infants
CALIFORNIA—(ENEWSPF)—July 19, 2018 By: Christina Jewett and Shefali Luthra The Trump administration has summoned at least 70 children under 1 year old to immigration court for their own deportation proceedings since Oct. 1, according to new Justice Department data provided exclusively to Kaiser Health News. These children, who may be[Read More…]
FDA Expands the Use of New Breast Cancer Drug
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency Silver Spring, Maryland—(ENEWSPF)—July 19, 2018 Contact: Sandy Walsh The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor[Read More…]
Lawsuit Challenges Trump Administration’s Expansion of Gulf of Mexico Drilling
Offshore drilling across 78 million acres will worsen climate change, ramp up risks to communities, wildlife Washington, DC—(ENEWSPF)—July 17, 2018 Contacts: Maggie Caldwell, Earthjustice, Dustin Renaud, Gulf Restoration Network, Gabby Brown, Sierra Club, and Kristen Monsell, Center for Biological Diversity Environmental groups sued the Trump administration today for opening up[Read More…]
Large Study Launched on Aggressive Prostate Cancer in African-American Men
Bethesda, Maryland—(ENEWSPF)—July 17, 2018 Contact: Rebecca Newton, NIMHD The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of[Read More…]
Water Pik, Inc. Recalls Sonic-Fusion® Flossing Toothbrush
Silver Spring, Maryland—(ENEWSPF)—July 16, 2018 Contact: Teresa Ricketts Water Pik, Inc. is voluntarily recalling its Sonic-Fusion® flossing toothbrush because the charging base may overheat with localized melting and sparking, possibly causing fire, shock or burns. Water Pik, Inc. has received consumer reports of product malfunctioning in the U.S. The recall[Read More…]
Calumet 2018 Outdoor Series ‘Walking the Freedom Trail’ on July 21
CHICAGO—(ENEWSPF)—July 14, 2018 By: Larry McClellan and Tom Shepherd The Calumet 2018 Outdoor Series ‘Walking the Freedom Trail’ will take place on Saturday, July 21 from 1 p.m. to 3 p.m. Join Tom Shepherd, a member of the Little Calumet Underground Railroad Project, as he guides a hike along the[Read More…]
FDA Announces Voluntary Recall of Several Cardiac Medicines Containing Valsartan
Possibly contains impurity Silver Spring, Maryland—(ENEWSPF)—July 14, 2018 Contact: Sandy Walsh he U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due[Read More…]
